Carcinoembryonic (CEA) and breast cancer associated 115D8/DF3 (CA15.3) antigens are the serum tumour markers commonly used for post-operative monitoring of breast cancer [1] although many other tumour markers have been investigated [12-17]. The gene discussed is CEACAM5; the disease is breast carcinoma.